196 related articles for article (PubMed ID: 15811994)
1. Proteomic profiling of recombinant Escherichia coli in high-cell-density fermentations for improved production of an antibody fragment biopharmaceutical.
Aldor IS; Krawitz DC; Forrest W; Chen C; Nishihara JC; Joly JC; Champion KM
Appl Environ Microbiol; 2005 Apr; 71(4):1717-28. PubMed ID: 15811994
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the Escherichia coli proteomes for recombinant human growth hormone producing and nonproducing fermentations.
Champion KM; Nishihara JC; Aldor IS; Moreno GT; Andersen D; Stults KL; Vanderlaan M
Proteomics; 2003 Jul; 3(7):1365-73. PubMed ID: 12872237
[TBL] [Abstract][Full Text] [Related]
3. High-level accumulation of a recombinant antibody fragment in the periplasm of Escherichia coli requires a triple-mutant (degP prc spr) host strain.
Chen C; Snedecor B; Nishihara JC; Joly JC; McFarland N; Andersen DC; Battersby JE; Champion KM
Biotechnol Bioeng; 2004 Mar; 85(5):463-74. PubMed ID: 14760686
[TBL] [Abstract][Full Text] [Related]
4. Similarity of the Escherichia coli proteome upon completion of different biopharmaceutical fermentation processes.
Champion KM; Nishihara JC; Joly JC; Arnott D
Proteomics; 2001 Sep; 1(9):1133-48. PubMed ID: 11990508
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of excretory production of an exoglucanase from Escherichia coli with phage shock protein A (PspA) overexpression.
Wang YY; Fu ZB; Ng KL; Lam CC; Chan AK; Sze KF; Wong WK
J Microbiol Biotechnol; 2011 Jun; 21(6):637-45. PubMed ID: 21715971
[TBL] [Abstract][Full Text] [Related]
6. Efficient soluble expression of disulfide bonded proteins in the cytoplasm of Escherichia coli in fed-batch fermentations on chemically defined minimal media.
Gąciarz A; Khatri NK; Velez-Suberbie ML; Saaranen MJ; Uchida Y; Keshavarz-Moore E; Ruddock LW
Microb Cell Fact; 2017 Jun; 16(1):108. PubMed ID: 28619018
[TBL] [Abstract][Full Text] [Related]
7. A comparative analysis of industrial Escherichia coli K-12 and B strains in high-glucose batch cultivations on process-, transcriptome- and proteome level.
Marisch K; Bayer K; Scharl T; Mairhofer J; Krempl PM; Hummel K; Razzazi-Fazeli E; Striedner G
PLoS One; 2013; 8(8):e70516. PubMed ID: 23950949
[TBL] [Abstract][Full Text] [Related]
8. proBA complementation of an auxotrophic E. coli strain improves plasmid stability and expression yield during fermenter production of a recombinant antibody fragment.
Fiedler M; Skerra A
Gene; 2001 Aug; 274(1-2):111-8. PubMed ID: 11675003
[TBL] [Abstract][Full Text] [Related]
9. Broad-host-range plasmid pJB658 can be used for industrial-level production of a secreted host-toxic single-chain antibody fragment in Escherichia coli.
Sletta H; Nedal A; Aune TE; Hellebust H; Hakvåg S; Aune R; Ellingsen TE; Valla S; Brautaset T
Appl Environ Microbiol; 2004 Dec; 70(12):7033-9. PubMed ID: 15574897
[TBL] [Abstract][Full Text] [Related]
10. Proteome analysis of Escherichia coli W3110 expressing an heterologous sigma factor.
Baglioni P; Bini L; Liberatori S; Pallini V; Marri L
Proteomics; 2003 Jun; 3(6):1060-5. PubMed ID: 12833530
[TBL] [Abstract][Full Text] [Related]
11. Monitoring of genes that respond to overproduction of an insoluble recombinant protein in Escherichia coli glucose-limited fed-batch fermentations.
Jürgen B; Lin HY; Riemschneider S; Scharf C; Neubauer P; Schmid R; Hecker M; Schweder T
Biotechnol Bioeng; 2000 Oct; 70(2):217-24. PubMed ID: 10972933
[TBL] [Abstract][Full Text] [Related]
12. Protein solubility and differential proteomic profiling of recombinant Escherichia coli overexpressing double-tagged fusion proteins.
Cheng CH; Lee WC
Microb Cell Fact; 2010 Aug; 9():63. PubMed ID: 20799977
[TBL] [Abstract][Full Text] [Related]
13. Studies of single-chain antibody expression in quiescent Escherichia coli.
Mukherjee KJ; Rowe DC; Watkins NA; Summers DK
Appl Environ Microbiol; 2004 May; 70(5):3005-12. PubMed ID: 15128562
[TBL] [Abstract][Full Text] [Related]
14. Proteome response of Escherichia coli fed-batch culture to temperature downshift.
Kim YH; Han KY; Lee K; Lee J
Appl Microbiol Biotechnol; 2005 Oct; 68(6):786-93. PubMed ID: 15983803
[TBL] [Abstract][Full Text] [Related]
15. Posttranslational Targeting of a Recombinant Protein Promotes Its Efficient Secretion into the Escherichia coli Periplasm.
Ytterberg AJ; Zubarev RA; Baumgarten T
Appl Environ Microbiol; 2019 Jul; 85(13):. PubMed ID: 31003980
[TBL] [Abstract][Full Text] [Related]
16. Microaerobic fermentation alters lactose metabolism in Escherichia coli.
Pandi K; Chauhan AS; Gupta JA; Rathore AS
Appl Microbiol Biotechnol; 2020 Jul; 104(13):5773-5785. PubMed ID: 32409946
[TBL] [Abstract][Full Text] [Related]
17. Phage shock protein and gene responses of Escherichia coli exposed to carbon nanotubes.
Anh Le TT; Thuptimdang P; McEvoy J; Khan E
Chemosphere; 2019 Jun; 224():461-469. PubMed ID: 30831497
[TBL] [Abstract][Full Text] [Related]
18. Coexpression of chaperonin GroEL/GroES markedly enhanced soluble and functional expression of recombinant human interferon-gamma in Escherichia coli.
Yan X; Hu S; Guan YX; Yao SJ
Appl Microbiol Biotechnol; 2012 Feb; 93(3):1065-74. PubMed ID: 21975693
[TBL] [Abstract][Full Text] [Related]
19. Development of a 3-hydroxypropionate resistant Escherichia coli strain.
Liu M; Han X; Xian M; Ding Y; Liu H; Zhao G
Bioengineered; 2016; 7(1):21-7. PubMed ID: 26709549
[TBL] [Abstract][Full Text] [Related]
20. Engineering Escherichia coli for increased productivity of serine-rich proteins based on proteome profiling.
Han MJ; Jeong KJ; Yoo JS; Lee SY
Appl Environ Microbiol; 2003 Oct; 69(10):5772-81. PubMed ID: 14532024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]